(19)

(11)

EP 3 911 414 A1

(12)

(43) Date of publication: 24.11.2021 Bulletin 2021/47 (21) Application number: 20701856.5 (22) Date of filing: 17.01.2020

(51) International Patent Classification (IPC):  A61P 31/14(2006.01) C07K 16/10(2006.01) (52) Cooperative Patent Classification (CPC): C07K 2317/76; C07K 2317/92; C07K 2317/33; C07K 16/10; A61K 2039/507; A61P 31/14 (86) International application number: PCT/GB2020/050103 (87) International publication number: WO 2020/148554 (23.07.2020 Gazette 2020/30)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 18.01.2019 GB 201900732 (71) Applicants: UCB Biopharma SRL 1070 Brussels (BE) Oxford University Innovation Limited Oxford, OX2 0JB (GB)

(72) Inventors: LIGHTWOOD, Daniel John Slough Berkshire SL1 3WE (GB) REDGRAVE-O'DOWD, Victoria, Louise Slough Berkshire SL1 3WE (GB) TOWNSEND, Alain Oxford Oxfordshire OX3 9DS (GB) RIJAL, Pramila Oxford Oxfordshire OX3 9DS (GB) SMITH, Lisa Marie Oxford Oxfordshire OX3 9DS (GB) DRAPER, Simon John Oxford Oxfordshire OX3 7DQ (GB) ELIAS, Sean Christopher Oxford Oxfordshire OX3 7DQ (GB) (74) Representative: J A Kemp LLP  80 Turnmill Street London EC1M 5QU London EC1M 5QU (GB)